MHMalihe Hasanzadeh

Malihe Hasanzadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Malihe Hasanzadeh has a total of 100 co-authors. Here are the top co-authors by number of shared publications:

  • Amir Avan

    Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    4 shared publications
  • Marjaneh Farazestanian

    Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    3 shared publications
  • Maryam Esmaeilpour

    Gynecologic Oncology Fellowship, Obstetrics and Gynecology Department, Faculty of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

    3 shared publications
  • Amirhosein Jafarian

    Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    2 shared publications
  • Habibollah Esmaily

    Department of Biostatistics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran

    2 shared publications
  • Majid Khazaei

    Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    2 shared publications

Latest Publications

  • Association Between Salivary and Cervical Human Papillomavirus in Women With a History of Oral Sex

    by Mahdieh Akbari, Zoha Mohammadi Pour Yazdi, Yasaman Yazdandoost, Negar Yavari, Maryam Amir Chakhmaghi, Zahra Abbasi Shaye, Masoumeh Ghorbanzadeh, Fatemeh Yazadani, Azadeh Vaseei, Malihe Hasanzadeh Mofrad, et al.

    Objective: Human papillomavirus (HPV) is a sexually transmitted DNA virus implicated in both cervical and oral squamous cell carcinomas (SCC). While HPV’s role in cervical cancer is well established, the prevalence of oral HPV in women with genital infection—particularly in relation to sexual practices—remains underexplored in Iran. This study aimed to investigate the presence of HPV DNA in the saliva of Iranian women with confirmed genital HPV infection and a history of oral-genital contact. Methods: In this cross-sectional study, 111 women aged 15–65 with diagnosed genital HPV were recruited between 2021 and 2024. Saliva samples were collected and analyzed using polymerase chain reaction (PCR) to detect HPV DNA. Demographic and behavioral data were obtained using a questionnaire. The association between salivary HPV presence and sexual practices, HPV genotype, and clinical variables was statistically assessed. Results: HPV DNA was detected in the saliva of 25 participants (22.1%). High-risk genotypes, particularly HPV-16, were significantly more prevalent among those with concurrent oral and genital infections ( p =.03). No statistically significant association was found between salivary HPV and smoking, alcohol use, or contraceptive method. Oral examinations in HPV-positive patients revealed no premalignant lesions. Conclusions: These findings indicate a notable prevalence of oral HPV in women with genital HPV, particularly those with high-risk genotypes; however, the clinical significance of salivary HPV detection remains uncertain, and routine oral HPV screening cannot currently be recommended. Further multicenter studies are warranted.

  • Comparable Survival of Grade 3 Endometrioid and Serous Endometrial Carcinoma, with TP53 Mutations

    by Maryam Esmaeilpour, Mohammad Mahdi Kakoienejad, Malihe Hasanzadeh, Marjaneh Farazestanian, Babak Goodarzy, Anita Alenabi

  • Open Access

    Ziziphus jujube promotes fertility and pregnancy outcomes in Rat model of uterine adhesions

    by Fereshteh Asgharzadeh, Mahsa Attarian, Majid Khazaei, Abdulridha Mohammed Al-Asady, Saeide Mansoori, Hamideh Naimi, Moein Eskandari, Azar Khorrami, Seyedeh Elnaz Nazari, Akram Aminian, et al.

    Introduction: The therapeutic efficacy of oral administration of Ziziphus jujube in the context of uterine adhesion (UA) and its impact on pregnancy outcomes was investigated.Methods: In a rat UA model, Z. jujube was evaluated for its ability to mitigate injury-induced uterine adhesion bands, uterine shortening, and enhance endometrial regeneration. The assessment included analysis of gland numbers, uterine endometrial thickness, and regulation of inflammatory cytokines. The antioxidant properties of Z. jujube were also studied through antioxidant enzyme activity in uterine tissue homogenates. Fibrotic changes were examined through histological Trichrome staining and analysis of pro-fibrotic factors.Results: Treatment with Z. jujube resulted in a significant reduction in uterine tissue fibrosis, as evidenced by histological evaluation and reduced expression of fibrotic markers. The intervention demonstrated positive outcomes in embryonic development, pregnancy rates, and pregnancy outcomes. Z. jujube effectively inhibited the formation of extra-uterine adhesion bands to internal organs. No toxicity-related morphological changes were observed in vital organs of the Z. Jujube-treated group.Discussion: The results collectively indicate that Z. jujube is a safe and potent natural product with anti-inflammatory and anti-fibrotic properties, highlighting its potential as a novel candidate for clinical studies targeting UA in patients.


  • Mixed Endometrioid Clear Cell Carcinoma of the Ovary: A Case Report

    by Malihe Hasanzadeh, Maryam Esmaeilpour, Mahdieh Mohammadi

    Background: Despite the high percentage of pure forms of epithelial ovarian cancers (EOC), mixed epithelial cancer of the ovary is extremely rare and accounts for less than 1% percent of all epithelial ovarian cancers. Because of the low prevalence; there are only a few cases of mixed epithelial cancers published in the literature. This study presents the case of a mixed endometrioid (EC)/clear cell carcinoma (CCC), diagnosed in a woman with a complaint of low back pain and a history of infertility. Case Report: We report the case of a 35-year-old woman who came to our clinic complaining of progressive back pain and a history of infertility. Imaging showed a left ovarian mass that was compatible with malignant tumors. The patient underwent open surgery and a frozen section evaluation of the tumor was done during the operation. The pathology result demonstrated mixed CCC/EC histology in the left ovary. We decided to perform a total abdominal hysterectomy as well as right salpingooophorectomy, omentectomy, bilateral pelvic lymphadenectomy, and para-aortic lymphadenectomy. Adjuvant chemotherapy was administrated postoperatively. Conclusion: Although epithelial cancers account for more than 90% of all ovarian cancers (OC), developing mixed forms of epithelial cancers is extremely rare, and there are little data available in the literature about their presentation and histopathological features. The main purpose of this article was to report a mixed CCC/EC and to discuss different aspects of this rare histologic type of OC. More research is needed to determine metastatic potential as well as the likelihood of recurrence of these unique neoplasms.

  • Comparative Investigation of Color Doppler Ultrasonography Parameters of the Uterine Artery in Patients with Post-molar GTN and Patients Recovered from Molar Pregnancy and its Role in Predicting the Probability of Occurrence

    by Malihe Hasanzadeh, Najmeh Jahani, Sara Mirzaeian, Maryam Esmaeilpour, Marjaneh Farazestanian

    Objectives: Hydatiform mole can progress to gestational trophoblastic neoplasia (GTN), and we are looking for non-invasive methods to predict it. Old age, higher serum BHCG levels, and expression of genes, such as VEGF-EG, HIF-1α, and TGF-ß are known as predictive factors. We performed this study to evaluate the role of bilateral uterine artery doppler ultrasound in predicting postmolar- GTN. Methods: In this prospective cohort study, 42 patients with complete molar pregnancy were examined. Inclusion criteria confirmed molar pregnancy by histopathological examination. Exclusion criteria were patients more than 40 years old, patients with completed family childbearing planning, and diagnosis of GTN during the routine histopathological study. Before molar evacuation and four weeks later, bilateral uterine artery doppler sonography to determine the PI, RI, and PSV was performed. Serum BHCG levels were also measured before molar evacuation and weekly after evacuation until it exhibited spontaneous remission or developed GTN. Results: About 36 patients were cured, and six others developed post-molar GTN. The bilateral uterine artery doppler sonography between the two groups showed a lower UA RI in the post-molar-GTN group before evacuation (P=0.048). Data demonstrated significant increases in Right.UA.RI (P=0/008), Left.UA.PI (P=0/037), and Right.UA.PSV (P=0/024) in the spontaneous remission group during 28 days follow-up period. There were no significant differences in these parameters in the GTN group throughout the time of follow-up. Conclusion: It seems that Doppler ultrasound plays a role in predicting GTN following uterine evacuation. A lower resistance in the uterine artery before evacuation and the remaining uterine artery blood flow constant after evacuation is associated with the development of post-molar- GTN.

  • Severe Lower Gastrointestinal Bleeding Due to Choriocarcinoma with AVM to the Ileum: A Case Report

    by Malihe Hasanzadeh, Najmeh Jahani, Farzaneh Khoroushi, Nourieh Sharifi

    Background: Choriocarcinoma and other placental tumors are rare, and metastasis to the gastrointestinal, especially the small bowel, is extremely rare. Furthermore, about 5% of all metastasis belongs to the GI tract. Case Presentation: We reported an 18 -year-old patient with severe GI bleeding. Serum BHCG level was 57322 mIU/mL. CT angiography and Pelvic MRI suggested a metastatic arteriovenous malformation to the small bowel. In surgery, we detected the AVM from the right side of the uterus to the ileum, and pathological findings confirmed the choriocarcinoma with metastatic AVM to the ileum. Conclusion: Chemotherapy started after surgery, and the patient was asymptomatic on follow-up after 14 months. The results showed that GTN was a differential diagnosis when patients are referred with these signs and symptoms. ConclusioN: Findings from this study suggest a high prevalence of paradoxical VL suppression but not immune CD4 gain in the studied subjects following cART. Larger studies are needed to corroborate these findings.


  • Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer

    by Negin Behboodi, Marjaneh Farazestanian, Azam Rastgar-Moghadam, Mehrane Mehramiz, Ehsan Karimi, Majid Rajabian, Farzad Rahmani, Shadi Khorrami, Amirhosein Jafarian, Noorieh Sharifi-Sistani, et al.

    Tumor necrosis factor alpha (TNF-α) is a pro-inflammatory cytokine involved in the regulation of the immune system and potentially the progression of cervical neoplastic lesions. In this study, we aimed to explore the possible relationship between polymorphisms of the TNF-α gene and susceptibility to cervical cancer. The relationship between a single nucleotide polymorphism (SNP) in the TNF-α gene (rs1800629) and the risk of cervical cancer was evaluated in a total of 445 subjects with (n = 153), or without (n = 292) cancer. Genotyping was performed using a Taq-Man based real time PCR method. Logistic regression analysis showed that individuals with AG/AA genotypes had an increased risk of cervical cancer compared to those with a GG genotype (OR 3.79, 95% CI 2.4–5.7, < 0.001). Our findings demonstrated that a genetic variant in the TNF-α gene (rs1800629) was associated with increased level and risk of developing cervical cancer, suggesting its potential use as a genetic risk factor for cervical neoplasia.


  • Open Access

    Vaginal Adenosis in Two Patients with No History of Diethylstilbestrol: A Case Report

    by Maliheh Hasanzadeh, Seyedeh Sara Nourbakhsh, Amir Hosein Jafarian, Parnian Malakuti

    Introduction: Vaginal adenosis is one of the precursor lesions of the vaginal clear cell adenocarcinoma (CCA). The most common symptom of vaginal adenosis is abnormal vaginal pain and bleeding. About 90% of women exposed to diethylstilbestrol (DES) during pregnancy have vaginal and cervical adenosis in female fetus. DES has been ...

  • Open Access

    An Ovarian Mass with Microcystic Stromal Tumor: A Rare Case Report

    by Malihe Hasanzadeh, Fereshteh Bazmi, Parnian Malakuti, Ghaem Hospital Freelance Researcher Student

    Background & Objective: Ovarian microcystic stromal tumor (MST) is a rare subset of ovarian tumors, that usually appears in the form of a pelvic mass which is often unilateral, and has a microcystic realization characterized by small, elliptical, and circular cysts. This microcystic stromal tumor is a type of ovarian insufficiency that has recently ...


  • Association of TNF‐308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smear

    by Nooshin Babapour, Mehrane Mehramiz, Azam Rastgar Moghadam, Negin Behboodi, Zohre Yousefi, Mona Maftouh, Sahar Talebian, Majid Khazaei, Amirhosein Jafarian, Noorieh Sharifi‐Sistani, et al.

    Tumor necrosis factor a (TNFa) is an inflammatory cytokine that plays a crucial role in the immune response and the progression of cervical lesions. There is a growing body of data evaluating the value of a genetic variant in the TNFa gene with the risk of developing cervical cancer. The aim of this study was to explore the association of a variant, TNF‐308 G>A, residing in the TNFa gene with cervical cancer. A total of 91 women with cervical cancer and 161 women as the control group were recruited. DNA was extracted, and Taqman®‐probes‐based assay was used for genotyping. Our results showed that the minor allele frequency was 0.3 in total population, and the frequency of minor allele A was more in the case group compared with the control. The regression models in different genetic models also revealed that the allele A is a potential risk factor for the development of cervical cancer. In particular, in the dominant model, patients with AG and AA genotypes had a higher risk of developing cervical cancer with odds ratio (OR) of 2.75 (95% confidence interval [CI]: 1.57‐4.83, <0.001) and OR of 7.27 (95%CI: 2.5‐20.8, A located on TNF‐a was associated with the risk of cervical cancer, supporting further studies in a larger population and multicenter setting to show the value of emerging markers as risk stratification biomarkers in cervical cancer.